Quarterly report pursuant to Section 13 or 15(d)

Nature of Business and Liquidity Nature of Business and Liquidity (Details)

v3.8.0.1
Nature of Business and Liquidity Nature of Business and Liquidity (Details)
9 Months Ended
Sep. 30, 2017
candidate
segment
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Number of drug candidates | candidate 4
Number of operating segments | segment 1